“Results of a phase 3 trial in the New England Journal of Medicine show 80% protection for the single-dose tetravalent (four-strain) Butantan-Dengue Vaccine among participants with no evidence of previous dengue exposure and 89% protection in those with a history of exposure.
The vaccine is the culmination of years of research from Brazil’s Butantan Institute, and the study included results from 16 Brazilian centers located in all five regions of the country.”
“Nearly 10 000 children in Burkina Faso and Cameroon have now received the RTS,S malaria vaccine since being introduced this year. A wider malaria vaccine rollout is underway this year in several African countries, with Cameroon being the first outside the malaria vaccine pilot programme to do so.”
“The world’s first routine vaccine programme against malaria has started in Cameroon, in a move projected to save thousands of children’s lives across Africa.
The symbolic first jab was given to a baby girl named Daniella at a health facility near Yaoundé on Monday.”
“The novel type 2 oral polio vaccine (nOPV2), developed by a team including scientists from the Medicines and Healthcare products Regulatory Agency, has today (9 January) been quality-assured (prequalified) by the World Health Organization…
Prequalification is a mark of quality assurance granted by the WHO and will make it easier for more countries to access and use nOPV2.”
From News Medical.